Global Adrenocortical Carcinoma Drugs Market Size, Status and Forecast 2019-2025

Choose License

The adrenocortical carcinoma drugs market has recorded the development of several advanced imaging techniques, which are non-invasive and exhibit enhanced diagnostic accuracy in the detection of adrenal lesions.
For instance, unenhanced computed tomography adrenal densitometry is used to differentiate adrenal adenomas from malignant lesions based on the presence of intracellular lipids. A combination of positron emission tomography/computed tomography is also gaining popularity among end-users for the identification of malignant and benign lesions. Similarly, multiphase computed tomography technique is being used to calculate absolute and relative percentage washout, and thereby, differentiate between benign and malignant lesions.
In 2018, the global Adrenocortical Carcinoma Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Adrenocortical Carcinoma Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adrenocortical Carcinoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
    Bristol-Myers Squibb Co.
    Eli Lilly and Co.
    Laboratoire HRA Pharma SAS
    Progenics Pharmaceuticals Inc.
    Teva Pharmaceutical Industries Ltd.
    ...

Market segment by Type, the product can be split into
    Chemotherapy
    Targeted therapy

Market segment by Application, split into
    Hospital
    Research institute
    Clinic
    Other

Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Adrenocortical Carcinoma Drugs status, future forecast, growth opportunity, key market and key players.
    To present the Adrenocortical Carcinoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Adrenocortical Carcinoma Drugs are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Adrenocortical Carcinoma Drugs Market Size Growth Rate by Type (2014-2025)
        1.4.2 Chemotherapy
        1.4.3 Targeted therapy
    1.5 Market by Application
        1.5.1 Global Adrenocortical Carcinoma Drugs Market Share by Application (2019-2025)
        1.5.2 Hospital
        1.5.3 Research institute
        1.5.4 Clinic
        1.5.5 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Adrenocortical Carcinoma Drugs Market Size
    2.2 Adrenocortical Carcinoma Drugs Growth Trends by Regions
        2.2.1 Adrenocortical Carcinoma Drugs Market Size by Regions (2019-2025)
        2.2.2 Adrenocortical Carcinoma Drugs Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Challenges
        2.3.4 Porter?s Five Forces Analysis

3 Market Share by Key Players
    3.1 Adrenocortical Carcinoma Drugs Market Size by by Players
        3.1.1 Global Adrenocortical Carcinoma Drugs Revenue by by Players (2014-2019)
        3.1.2 Global Adrenocortical Carcinoma Drugs Revenue Market Share by by Players (2014-2019)
        3.1.3 Global Adrenocortical Carcinoma Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Adrenocortical Carcinoma Drugs Key Players Head office and Area Served
    3.3 Key Players Adrenocortical Carcinoma Drugs Product/Solution/Service
    3.4 Date of Enter into Adrenocortical Carcinoma Drugs Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Adrenocortical Carcinoma Drugs Market Size by Type (2014-2019)
    4.2 Global Adrenocortical Carcinoma Drugs Market Size by Application (2014-2019)

5 North America
    5.1 North America Adrenocortical Carcinoma Drugs Market Size (2014-2019)
    5.2 Adrenocortical Carcinoma Drugs Key Players in North America
    5.3 North America Adrenocortical Carcinoma Drugs Market Size by Type
    5.4 North America Adrenocortical Carcinoma Drugs Market Size by Application

6 Europe
    6.1 Europe Adrenocortical Carcinoma Drugs Market Size (2014-2019)
    6.2 Adrenocortical Carcinoma Drugs Key Players in Europe
    6.3 Europe Adrenocortical Carcinoma Drugs Market Size by Type
    6.4 Europe Adrenocortical Carcinoma Drugs Market Size by Application

7 China
    7.1 China Adrenocortical Carcinoma Drugs Market Size (2014-2019)
    7.2 Adrenocortical Carcinoma Drugs Key Players in China
    7.3 China Adrenocortical Carcinoma Drugs Market Size by Type
    7.4 China Adrenocortical Carcinoma Drugs Market Size by Application

8 Japan
    8.1 Japan Adrenocortical Carcinoma Drugs Market Size (2014-2019)
    8.2 Adrenocortical Carcinoma Drugs Key Players in Japan
    8.3 Japan Adrenocortical Carcinoma Drugs Market Size by Type
    8.4 Japan Adrenocortical Carcinoma Drugs Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Adrenocortical Carcinoma Drugs Market Size (2014-2019)
    9.2 Adrenocortical Carcinoma Drugs Key Players in Southeast Asia
    9.3 Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Type
    9.4 Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Application

10 India
    10.1 India Adrenocortical Carcinoma Drugs Market Size (2014-2019)
    10.2 Adrenocortical Carcinoma Drugs Key Players in India
    10.3 India Adrenocortical Carcinoma Drugs Market Size by Type
    10.4 India Adrenocortical Carcinoma Drugs Market Size by Application

11 Central & South America
    11.1 Central & South America Adrenocortical Carcinoma Drugs Market Size (2014-2019)
    11.2 Adrenocortical Carcinoma Drugs Key Players in Central & South America
    11.3 Central & South America Adrenocortical Carcinoma Drugs Market Size by Type
    11.4 Central & South America Adrenocortical Carcinoma Drugs Market Size by Application

12 International Players Profiles
    12.1 Bristol-Myers Squibb Co.
        12.1.1 Bristol-Myers Squibb Co. Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Adrenocortical Carcinoma Drugs Introduction
        12.1.4 Bristol-Myers Squibb Co. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019))
        12.1.5 Bristol-Myers Squibb Co. Recent Development
    12.2 Eli Lilly and Co.
        12.2.1 Eli Lilly and Co. Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Adrenocortical Carcinoma Drugs Introduction
        12.2.4 Eli Lilly and Co. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
        12.2.5 Eli Lilly and Co. Recent Development
    12.3 Laboratoire HRA Pharma SAS
        12.3.1 Laboratoire HRA Pharma SAS Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Adrenocortical Carcinoma Drugs Introduction
        12.3.4 Laboratoire HRA Pharma SAS Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
        12.3.5 Laboratoire HRA Pharma SAS Recent Development
    12.4 Progenics Pharmaceuticals Inc.
        12.4.1 Progenics Pharmaceuticals Inc. Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Adrenocortical Carcinoma Drugs Introduction
        12.4.4 Progenics Pharmaceuticals Inc. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
        12.4.5 Progenics Pharmaceuticals Inc. Recent Development
    12.5 Teva Pharmaceutical Industries Ltd.
        12.5.1 Teva Pharmaceutical Industries Ltd. Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Adrenocortical Carcinoma Drugs Introduction
        12.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
        12.5.5 Teva Pharmaceutical Industries Ltd. Recent Development

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Product (2019-2025)
    13.2 Market Size Forecast by Application (2019-2025)
    13.3 Market Size Forecast by Regions
    13.4 North America
    13.5 Europe
    13.6 China
    13.7 Japan
    13.8 Southeast Asia
    13.9 India
    13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures Table Adrenocortical Carcinoma Drugs Key Market Segments Table Key Players Adrenocortical Carcinoma Drugs Covered Table Global Adrenocortical Carcinoma Drugs Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Chemotherapy Figures Table Key Players of Chemotherapy Figuer Targeted therapy Figures Table Key Players of Targeted therapy Table Global Adrenocortical Carcinoma Drugs Market Size Growth by Application 2019-2025 (Million US$) Figure Global Adrenocortical Carcinoma Drugs Market Share by Application in 2018 & 2025 Figure Hospital Case Studies Figure Research institute Case Studies Figure Clinic Case Studies Figure Other Case Studies Figure Adrenocortical Carcinoma Drugs Report Years Considered Figure Global Adrenocortical Carcinoma Drugs Market Size and Growth Rate 2014-2025 (Million US$) Table Global Adrenocortical Carcinoma Drugs Market Size by Regions 2019-2025 (Million US$) Table Global Adrenocortical Carcinoma Drugs Market Size by Regions 2019-2025 (Million US$) Table Global Adrenocortical Carcinoma Drugs Market Share by Regions 2014-2019 Figure Global Adrenocortical Carcinoma Drugs Market Share by Regions 2014-2019 Figure Global Adrenocortical Carcinoma Drugs Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Adrenocortical Carcinoma Drugs Revenue by by Players (2014-2019) (Million US$) Table Global Adrenocortical Carcinoma Drugs Market Share by by Players (2014-2019) Figure Global Adrenocortical Carcinoma Drugs Market Share by by Players in 2018 Table Global Adrenocortical Carcinoma Drugs by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Adrenocortical Carcinoma Drugs Product/Solution/Service Table Date of Enter into Adrenocortical Carcinoma Drugs Market Table Mergers & Acquisitions, Expansion Plans Table Global Adrenocortical Carcinoma Drugs Market Size by Type (2014-2019) (Million US$) Table Global Adrenocortical Carcinoma Drugs Market Size Share by Type (2014-2019) Figure Global Adrenocortical Carcinoma Drugs Market Size Market Share by Type (2014-2019) Table Global Adrenocortical Carcinoma Drugs Market Size by Application (2014-2019) (Million US$) Table Global Adrenocortical Carcinoma Drugs Market Size Share by Application (2014-2019) Figure Global Adrenocortical Carcinoma Drugs Market Size Market Share by Application (2014-2019) Figure Global Adrenocortical Carcinoma Drugs Revenue Market Share by Application in 2018 Figure North America Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$) Table North America Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$) Table North America Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019) Table North America Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$) Table North America Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019 Table North America Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$) Table North America Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019 Figure Europe Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$) Table Europe Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$) Table Europe Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019) Table Europe Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$) Table Europe Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019 Table Europe Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$) Table Europe Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019 Figure China Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$) Table China Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$) Table China Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019) Table China Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$) Table China Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019 Table China Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$) Table China Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019 Figure Japan Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$) Table Japan Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$) Table Japan Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019) Table Japan Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$) Table Japan Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019 Table Japan Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$) Table Japan Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019 Figure Southeast Asia Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019) Table Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019 Table Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019 Figure India Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$) Table India Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$) Table India Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019) Table India Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$) Table India Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019 Table India Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$) Table India Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019 Figure Central & South America Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$) Table Central & South America Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$) Table Central & South America Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019) Table Central & South America Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$) Table Central & South America Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019 Table Central & South America Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$) Table Central & South America Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019 Table Bristol-Myers Squibb Co. Company Details Table Bristol-Myers Squibb Co. Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$) Figure Bristol-Myers Squibb Co. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019) Table Bristol-Myers Squibb Co. Recent Development Table Eli Lilly and Co. Company Details Table Eli Lilly and Co. Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$) Figure Eli Lilly and Co. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019) Table Eli Lilly and Co. Recent Development Table Laboratoire HRA Pharma SAS Company Details Table Laboratoire HRA Pharma SAS Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$) Figure Laboratoire HRA Pharma SAS Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019) Table Laboratoire HRA Pharma SAS Recent Development Table Progenics Pharmaceuticals Inc. Company Details Table Progenics Pharmaceuticals Inc. Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$) Figure Progenics Pharmaceuticals Inc. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019) Table Progenics Pharmaceuticals Inc. Recent Development Table Teva Pharmaceutical Industries Ltd. Company Details Table Teva Pharmaceutical Industries Ltd. Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$) Figure Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019) Table Teva Pharmaceutical Industries Ltd. Recent Development Table Global Adrenocortical Carcinoma Drugs Market Size by Regions (Million US$) 2019-2025 Figure Global Adrenocortical Carcinoma Drugs Market Size Share by Regions (2019-2025) Figure Global Adrenocortical Carcinoma Drugs Market Size Share by Regions in 2025 Figure North America Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD) Figure Europe Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD) Figure China Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD) Figure Japan Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD) Figure India Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD) Table Global Adrenocortical Carcinoma Drugs Market Size by Product (2019-2025) (Million US$) Figure Global Adrenocortical Carcinoma Drugs Market Size by Product (2019-2025) Figure Global Adrenocortical Carcinoma Drugs Market Size by Product in 2025 Table Global Adrenocortical Carcinoma Drugs Market Size by Application (2019-2025) (Million US$) Figure Global Adrenocortical Carcinoma Drugs Market Size by Application (2019-2025) Figure Global Adrenocortical Carcinoma Drugs Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global (United States, European Union and China) Intelligent Motor Controller Market Research Report 2019-2025

Intelligent motor controller is the next technology in motor control centers. Motor control centers (MCC) are used to carry out functions such as power switching, short-circuit protection, and overload protection, local and remote actuation, and cont...

Global (United States, European Union and China) Heavy Trucks Market Research Report 2019-2025

Heavy Machinery (Large Trucks) is the largest trucks allowed on the road, mostly used for long-haul purposes. Heavy Machinery (Large Trucks) constitutes an essential part of trucking industry. The trucking industry provides a vital service to the eco...

Global (United States, European Union and China) Compounded Resins Market Research Report 2019-2025

Compounded resins are obtained by mixing base polymers with additives for enhancing the properties of polymers. This process is called compounding, and it improves the physical, thermal, and electrical, and aesthetic characteristics of polymers. Our...

Global (United States, European Union and China) Automotive Natural Gas Vehicles Market Research Report 2019-2025

Automotive Natural Gas Vehicles refer To CNG vehicles. Compressed natural gas vehicle is an alternative fuel vehicle that uses compressed natural gas as the fuel rather than gasoline or diesel. CNG, or compressed natural gas, is stored at high pressu...

Global (United States, European Union and China) Aquatic Feed Ingredients and Products Market Research Report 2019-2025

Rice bran and wheat bran are conventionally used in aquaculture feeds. Non-conventional aquaculture feed ingredients such as blood meal, meat meal, bone meal, poultry feather meal, poultry by-product meal, guar gum, gram chunies and by-products from ...

New Pharmaceuticals and Healthcare Reports